Company profile for Leaps by Bayer

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Leaps by Bayer invests in paradigm-shifting advances in the life sciences – breakthroughs that could change the world for the better.We’re all driven by something. That’s why we climb the tallest mountains, try to reach the surface of the moon or dive into the deepest abyss. For us, it’s the next breakthrough in life sciences. With our ambitious targets, the risk of failure is high. But to achieve the impact we seek, ...
Leaps by Bayer invests in paradigm-shifting advances in the life sciences – breakthroughs that could change the world for the better.We’re all driven by something. That’s why we climb the tallest mountains, try to reach the surface of the moon or dive into the deepest abyss. For us, it’s the next breakthrough in life sciences. With our ambitious targets, the risk of failure is high. But to achieve the impact we seek, we must have the courage to leap.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Leverkusen, Nordrhein-Westfalen,
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250120806580/en

BUSINESSWIRE
20 Jan 2025
ReCode breaks the mold with $120M financing, Big Pharma backing
ReCode breaks the mold with $120M financing, Big Pharma backing

28 Jun 2022

// Gabrielle Masson FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/recode-therapeutics-breaks-funding-algorithm-200m-oversubscribed-series-b-amid-push-get

Gabrielle Masson FIERCEBIOTECH
28 Jun 2022

https://www.globenewswire.com/news-release/2022/05/24/2449375/0/en/Senti-Bio-Secures-Additional-Financing-from-Leaps-by-Bayer-and-Provides-Update-on-Proposed-Business-Combination-with-Dynamics-Special-Purpose-Corp-DYNS.html

GLOBENEWSWIRE
24 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty